Login to Your Account

Clinic Roundup

Monday, October 3, 2011
PharmaNeuroBoost NV, of Alken, Belgium, enrolled its first patients in a Phase III trial of its depression candidate, PNB01.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription